SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANFRINATO, Maria Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.659
AS - Asia 3.665
EU - Europa 2.110
SA - Sud America 565
Continente sconosciuto - Info sul continente non disponibili 143
AF - Africa 90
OC - Oceania 7
Totale 13.239
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.483
SG - Singapore 1.328
CN - Cina 981
BR - Brasile 424
IT - Italia 409
VN - Vietnam 408
UA - Ucraina 316
DE - Germania 315
HK - Hong Kong 274
GB - Regno Unito 236
TR - Turchia 166
FI - Finlandia 165
PL - Polonia 122
FR - Francia 116
BD - Bangladesh 113
JP - Giappone 97
RU - Federazione Russa 97
SE - Svezia 91
CA - Canada 88
IN - India 70
MX - Messico 54
ID - Indonesia 46
AR - Argentina 44
NL - Olanda 41
EE - Estonia 37
IQ - Iraq 29
ZA - Sudafrica 28
BE - Belgio 26
CO - Colombia 26
EC - Ecuador 25
ES - Italia 23
CZ - Repubblica Ceca 22
MA - Marocco 18
MY - Malesia 17
LT - Lituania 14
PK - Pakistan 14
SA - Arabia Saudita 14
PY - Paraguay 13
JM - Giamaica 12
UZ - Uzbekistan 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
IE - Irlanda 11
IR - Iran 11
PH - Filippine 10
AT - Austria 8
CL - Cile 8
ET - Etiopia 8
KE - Kenya 8
RO - Romania 8
EG - Egitto 7
KR - Corea 7
NP - Nepal 7
TN - Tunisia 7
TW - Taiwan 7
UY - Uruguay 7
AL - Albania 6
BG - Bulgaria 6
KZ - Kazakistan 6
PT - Portogallo 6
SD - Sudan 6
PS - Palestinian Territory 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AU - Australia 4
BO - Bolivia 4
EU - Europa 4
HN - Honduras 4
LB - Libano 4
LV - Lettonia 4
MD - Moldavia 4
OM - Oman 4
BH - Bahrain 3
CH - Svizzera 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
KW - Kuwait 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
NI - Nicaragua 2
PE - Perù 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AW - Aruba 1
BW - Botswana 1
CD - Congo 1
Totale 13.088
Salva come PNG Salva come JPEG
Città #
Singapore 855
Ashburn 676
San Jose 596
Woodbridge 521
Fairfield 340
Beijing 334
Jacksonville 331
Chandler 324
Santa Clara 317
Houston 314
Ann Arbor 281
Hong Kong 266
Council Bluffs 212
Dallas 142
Wilmington 139
Ferrara 133
Ho Chi Minh City 133
Seattle 114
Cambridge 113
Nanjing 110
Los Angeles 108
Warsaw 107
Izmir 100
Tokyo 95
Munich 87
Princeton 81
Hanoi 80
New York 80
Boardman 69
Lauterbourg 62
Helsinki 61
Milan 59
Dearborn 57
São Paulo 42
Shanghai 38
Nanchang 37
Buffalo 35
Shenyang 35
San Diego 34
Phoenix 33
Turku 33
London 31
Mexico City 31
Tianjin 30
Changsha 29
Montreal 27
Orem 27
Bologna 26
Brussels 26
Toronto 26
Chennai 23
Jakarta 22
Chicago 21
Poplar 21
Da Nang 20
The Dalles 20
Bremen 19
Brooklyn 19
Denver 19
Frankfurt am Main 19
Brno 18
Hefei 18
San Francisco 18
Jiaxing 17
Boston 16
Hebei 16
Atlanta 15
Haiphong 15
Moscow 15
Ningbo 15
Orange 15
Stockholm 15
Addison 14
Rome 14
Jinan 13
Norwalk 13
Manchester 12
Philadelphia 12
San Mateo 12
Amsterdam 11
Augusta 11
Dublin 11
Redwood City 11
Washington 11
Hillsboro 10
Mountain View 10
Quito 10
Tashkent 10
Auburn Hills 9
Baghdad 9
Brasília 9
Charlotte 9
Curitiba 9
Dong Ket 9
Guangzhou 9
Johannesburg 9
Kraków 9
Ninh Bình 9
Kingston 8
Kuala Lumpur 8
Totale 8.524
Salva come PNG Salva come JPEG
Nome #
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 282
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 259
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 253
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 249
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 249
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 229
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 224
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 219
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 211
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 208
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 202
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 202
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 199
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 198
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 197
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 197
Mutual communication of envelope glycoproteins of paramixoviruses 196
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 196
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 195
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 194
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 192
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 191
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 187
Substrate binding to 6-phosphogluconate dehydrogenase 187
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 183
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 181
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 180
Biochemical study in adult population with stroke in Ferrara, Fabry disease 179
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 175
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 175
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 171
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 171
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 168
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 168
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 160
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 160
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 159
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 158
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 156
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 154
Domain structure of the hemagglutinin-neuraminidase from sendai virus 150
Purification of transglutaminase enzyme from L. infantum promastigotes 148
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 147
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 147
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 147
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 145
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 142
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 141
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 140
Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high energy intermediate and transition state analogues 137
MMP-9 isoforms in serum of Multiple Sclerosis patients 136
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 136
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 135
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 131
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 130
Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: beyond the pentose phosphate pathway 129
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 129
Thermodynamic characterization of 6-phosphogluconate dehydrogenase ternary complex 129
null 128
Enzymatic activation of NCX4016, a nitrate ester derivative of Aspirin 127
Effects of anticoagulants on the activity of gelatinases 125
Unfording and limited proteolysis of the hemagglutinin-neuraminidase from sendai virus 116
Partial unfolding of the hemagglutinin-neuraminidase from sendai virus 114
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 114
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases 112
Effects of anticoagulants on the activity of gelatinases 112
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 111
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 111
Synthetic peptides corresponding to the heptad repeat region of sendai virus fusion protein bind to the hemagglutinin-neuraminidase 110
null 110
Xenobiotics biodegradation: recombinant DCM dehalogenase from alcaligenes xylosoxydans 106
null 104
Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action 102
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 101
The influence of different replacement solutions on neutrophils response 100
Modulation of metalloproteinase-9 (MMP-9) by its specific tissue inhibitor (TIMP1) 98
Lactoferrin administration prior to genetic amniocentesis dampens the intraamniotic inflammatory response 98
null 97
inhibition of sendai virus fusion protein by interaction synthetic peptides derived F protein and hemagglutinin-neuraminidase 96
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. 92
null 88
Commentary on the Issue of Leishmania Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects 84
pH dependent structural changes of the hemagglutinin-neuraminidase from sendai virus 83
Influence of different strategies of volume replacement on the activity of metalloproteinases 9 63
BACE-1 and ADAM-10 as Potential Peripheral Biomarkers for Alzheimer’s Disease 62
null 53
null 49
Sex differences in biomarkers: Implications for age-related diseases 38
Sex and Gender in Ageing and Longevity: Highlights from an International Course 22
Totale 13.239
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 171
Totale 59.096
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022548 0 0 26 21 27 25 19 25 19 71 45 270
2022/2023791 77 66 20 95 134 106 47 69 84 11 52 30
2023/2024407 42 48 16 15 61 40 10 24 17 12 8 114
2024/20251.818 49 42 153 73 216 152 68 98 263 232 276 196
2025/20265.126 502 227 410 610 685 322 655 285 474 547 263 146
2026/2027608 149 295 164 0 0 0 0 0 0 0 0 0
Totale 13.239